TransMedics Group (TMDX) Revenue & Revenue Breakdown
TransMedics Group Revenue Highlights
Latest Revenue (Y)
$241.62M
Latest Revenue (Q)
$114.31M
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
TransMedics Group Revenue by Period
TransMedics Group Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $241.62M | 158.53% |
| 2022-12-31 | $93.46M | 208.83% |
| 2021-12-31 | $30.26M | 18.03% |
| 2020-12-31 | $25.64M | 8.62% |
| 2019-12-28 | $23.60M | 81.33% |
| 2018-12-31 | $13.02M | 69.38% |
| 2017-12-31 | $7.68M | 23.77% |
| 2016-12-31 | $6.21M | - |
TransMedics Group generated $241.62M in revenue during NA 2023, up 158.53% compared to the previous quarter, and up 1856.21% compared to the same period a year ago.
TransMedics Group Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $114.31M | 18.02% |
| 2024-03-31 | $96.85M | 19.31% |
| 2023-12-31 | $81.17M | 22.19% |
| 2023-09-30 | $66.43M | 26.62% |
| 2023-06-30 | $52.47M | 26.26% |
| 2023-03-31 | $41.55M | 32.44% |
| 2022-12-31 | $31.38M | 22.16% |
| 2022-09-30 | $25.68M | 25.15% |
| 2022-06-30 | $20.52M | 29.23% |
| 2022-03-31 | $15.88M | 64.25% |
| 2021-12-31 | $9.67M | 80.04% |
| 2021-09-30 | $5.37M | -34.28% |
| 2021-06-30 | $8.17M | 15.85% |
| 2021-03-31 | $7.05M | -7.53% |
| 2020-12-31 | $7.63M | 7.56% |
| 2020-09-30 | $7.09M | 109.11% |
| 2020-06-30 | $3.39M | -54.97% |
| 2020-03-31 | $7.53M | 24.32% |
| 2019-12-28 | $6.06M | -15.93% |
| 2019-09-28 | $7.21M | 27.16% |
| 2019-06-29 | $5.67M | 21.17% |
| 2019-03-30 | $4.68M | 31.94% |
| 2018-12-31 | $3.54M | -12.26% |
| 2018-09-30 | $4.04M | 38.56% |
| 2018-06-30 | $2.92M | 15.72% |
| 2018-03-31 | $2.52M | - |
TransMedics Group generated $114.31M in revenue during Q2 2024, up 18.02% compared to the previous quarter, and up 275.08% compared to the same period a year ago.
TransMedics Group Revenue Breakdown
TransMedics Group Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Service Revenue | $65.55M | $14.22M | - | - | - |
| Product | $176.05M | $79.23M | - | - | - |
| Ocs Heart Product | - | - | $17.68M | $14.20M | $11.44M |
| Ocs Liver Product | - | - | $1.91M | $5.25M | $3.50M |
| Ocs Lung Product | - | - | $10.66M | $6.19M | $8.66M |
TransMedics Group's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (72.87%), and Service Revenue (27.13%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $42.57M | $35.52M | $14.68M | $10.00M | $7.56M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Product | $71.73M | $61.33M | $88.51M | $11.09M | $42.46M | $33.99M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Ocs Liver Product | - | - | - | - | - | - | $12.54M | $9.62M | $7.87M | $1.47M | - | - | $442.00K | $2.12M | $1.00M | $736.00K | - | $1.35M | $804.00K | - |
| Ocs Heart Product | - | - | - | - | - | - | $11.54M | $8.06M | $5.71M | $6.05M | $2.85M | $4.60M | $4.18M | $2.42M | $5.43M | $2.22M | $3.14M | $3.74M | $2.64M | - |
| Ocs Lung Product | - | - | - | - | - | - | $1.60M | $2.84M | $2.30M | $2.14M | $2.52M | $3.57M | $2.43M | $3.09M | $659.00K | $435.00K | $2.92M | $2.11M | $2.22M | - |
| OCS Liver Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.39M | - | - | - |
| OCS Heart Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.13M | - | - | - |
| OCS Lung Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.01M | - | - | - |
TransMedics Group's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (62.75%), and Service (37.25%).
TransMedics Group Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| UNITED STATES | $7.97M | $21.86M | $19.24M | $16.25M |
| Other Countries | $880.00K | $3.97M | - | - |
| Non Us And Uk | - | $8.40M | $6.40M | - |
| GERMANY | - | - | - | $1.15M |
TransMedics Group's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (90.05%), and Other Countries (9.95%).
Quarterly Revenue by Country
| Country | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $2.82M | $37.50M | $29.05M | $23.29M | $18.14M | $13.56M | $7.23M | $5.76M | $5.76M | $5.67M | $5.92M | $2.44M | $5.21M | $4.66M | $4.34M | $4.30M | $2.95M | - |
| Other Countries | $403.00K | $4.05M | $2.32M | $2.40M | $1.20M | $1.65M | $139.00K | - | - | - | - | - | - | - | - | - | - | - |
| Non Us And Uk | - | - | - | - | $2.38M | $2.32M | $4.36M | $1.90M | $1.31M | $824.00K | $4.10M | $491.00K | $596.00K | - | - | - | - | - |
| U S | - | - | - | - | - | - | - | $3.11M | - | - | - | - | - | - | - | - | - | - |
| Non US And UK | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.21M | - | - | - | - |
| GERMANY | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $276.00K | $194.00K | $358.00K | - |
| AUSTRALIA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $251.00K | $175.00K | - |
| ITALY | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $287.00K | - |
| Non-US | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.72M |
TransMedics Group's latest quarterly revenue breakdown by geography, as of Jun 23: UNITED STATES (87.48%), and Other Countries (12.52%).
TransMedics Group Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MASI | Masimo | $2.05B | $492.80M |
| PODD | Insulet | $1.70B | $488.50M |
| PEN | Penumbra | $1.06B | $299.40M |
| SWAV | ShockWave Medical | $730.23M | $218.81M |
| INSP | Inspire Medical Systems | $624.80M | $195.88M |
| NARI | Inari Medical | $493.63M | $145.82M |
| INMD | InMode | $492.05M | $80.28M |
| TMDX | TransMedics Group | $241.62M | $114.31M |
| SILK | Silk Road Medical | $177.13M | $48.48M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| TELA | TELA Bio | $58.45M | $16.09M |
| CVRX | CVRx | $39.30M | $11.81M |
| DCTH | Delcath Systems | $2.06M | $7.77M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
TMDX Revenue FAQ
What is TransMedics Group’s yearly revenue?
TransMedics Group's yearly revenue for 2023 was $241.62M, representing an increase of 158.53% compared to 2022. The company's yearly revenue for 2022 was $93.46M, representing an increase of 208.83% compared to 2021. TMDX's yearly revenue for 2021 was $30.26M, representing an increase of 18.03% compared to 2020.
What is TransMedics Group’s quarterly revenue?
TransMedics Group's quarterly revenue for Q2 2024 was $114.3M, a 18.02% increase from the previous quarter (Q1 2024), and a 117.87% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $96.85M, a 19.31% increase from the previous quarter (Q4 2023), and a 133.07% increase year-over-year (Q1 2023). TMDX's quarterly revenue for Q4 2023 was $81.17M, a 22.19% increase from the previous quarter (Q3 2023), and a 158.72% increase year-over-year (Q4 2022).
What is TransMedics Group’s revenue growth rate?
TransMedics Group's revenue growth rate for the last 3 years (2021-2023) was 698.44%, and for the last 5 years (2019-2023) was 923.65%.
What are TransMedics Group’s revenue streams?
TransMedics Group's revenue streams in c 23 are Service Revenue, and Product. Service Revenue generated $65.55M in revenue, accounting 27.13% of the company's total revenue, up 360.84% year-over-year. Product generated $176.05M in revenue, accounting 72.87% of the company's total revenue, up 122.19% year-over-year.
What is TransMedics Group’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of TransMedics Group was Product. This segment made a revenue of $176.05M, representing 72.87% of the company's total revenue.